Moreover, both WIS and TCGA cohorts demonstrated co-clustering of tumor and NAT samples when comparing beta-diversity scores, supporting similar tumor and NAT compositions (Figure 3G; Data S3.2J). The gene discussed is BRD2; the disease is neoplasm.